The purpose of this legislation is to speed up the approval process for certain nonprescription drugs that could significantly benefit public health. It aims to create a system where drugs that meet specific criteria can be designated as priority nonprescription drugs, allowing for a more efficient review and approval process. Key provisions of the legislation include the ability for drug sponsors to request a priority designation for their nonprescription drugs. The Secretary of Health and Human Services must respond to these requests within 60 days.